KMTS KESTRA MEDICAL TECHNOLOGIES, LTD.
Debt Financing ·
Kestra Medical drew $75.0 million from a facility of up to $200.0 million. The Tranche A loan funded on July 10, 2026, and repaid a prior loan from Perceptive Credit Holdings IV, LP.
We have not published a story on KESTRA MEDICAL TECHNOLOGIES, LTD. yet. When there is news, it will appear here.
| Line | FY ended Apr 30, 2026 | FY ended Apr 30, 2025 |
|---|---|---|
| Revenue | $95.1 million | $59.8 million |
| Research and development | $19.5 million | $15.7 million |
| Net income (loss) | -$131.6 million | -$113.8 million |
| Cash from operations | -$81.7 million | -$77.6 million |
| Cash and equivalents | $99.7 million | $237.6 million |
| Short-term investments | $96.7 million |
KESTRA MEDICAL TECHNOLOGIES, LTD. trades under the ticker KMTS on NASDAQ.
KESTRA MEDICAL TECHNOLOGIES, LTD. is listed on NASDAQ.
Our directory records KESTRA MEDICAL TECHNOLOGIES, LTD. under United States.
aibio.space lists KESTRA MEDICAL TECHNOLOGIES, LTD. among 2,820 public biotech companies and publishes its news here as stories appear.
$95.1 million for the fiscal year ended Apr 30, 2026, as reported to the SEC.
KESTRA MEDICAL TECHNOLOGIES, LTD. reported a net loss of $131.6 million for the fiscal year ended Apr 30, 2026, and used $81.7 million of cash in operations, per its annual report to the SEC.
$19.5 million in the fiscal year ended Apr 30, 2026, per its annual report.
$198.9 million in cash and short-term investments at Jul 31, 2026, per its 10-Q.
Our latest story on KESTRA MEDICAL TECHNOLOGIES, LTD., dated Jul 10, 2026: "Kestra Medical draws $75.0 million from up to $200.0 million term loan". Kestra Medical drew $75.0 million from a facility of up to $200.0 million. The Tranche A loan funded on July 10, 2026, and repaid a prior loan from Perceptive Credit Holdings IV, LP. Source.
Our latest debt story, dated Jul 10, 2026: "Kestra Medical draws $75.0 million from up to $200.0 million term loan". Kestra Medical drew $75.0 million from a facility of up to $200.0 million. The Tranche A loan funded on July 10, 2026, and repaid a prior loan from Perceptive Credit Holdings IV, LP. Source.
Press Follow on this page to add KESTRA MEDICAL TECHNOLOGIES, LTD. to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming KESTRA MEDICAL TECHNOLOGIES, LTD. so far, in Debt Financing.
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio